Submit Your Inquiry

If you have questions about any of the topics below, please click the link to visit the related Adaptive Biotechnologies webpage to learn more.

CLONOSEQ NGS-Based MRD TECHNOLOGYCLONOSEQ CLINICAL DATACLONOSEQ REPORTS

If you have additional questions, please fill out the Medical Information request form below:

Please confirm that you agree you are requesting medical information and certify that you are a physician or healthcare provider, that you are not including any Protected Health Information (PHI), and that the terms of the Adaptive Online Privacy Policy, Terms of Use, HIPAA Notice, and any other Adaptive policies apply.

Submit Your Inquiry

If you have questions about any of the topics below, please click the link to visit the related Adaptive Biotechnologies webpage to learn more.

ORDERING CLONOSEQCLONOSEQ REPORTS

ClonoSEQ ProductInquiry TestSpecimenRequirements REV2 514ea629
CLONOSEQ TEST
SPECIMEN REQUIREMENTS
Download

Our Clinical Services team can also help answer your questions. To speak with a Clinical Services Specialist, please email dxsupport@adaptivebiotech.com.

If you have additional questions, please fill out the Medical Information request form below:

    Please confirm that you agree you are requesting medical information and certify that you are a physician or healthcare provider, that you are not including any Protected Health Information (PHI), and that the terms of the Adaptive Online Privacy Policy, Terms of Use, HIPAA Notice, and any other Adaptive policies apply.

    Review Support Materials or Give Us a Call

    If you have questions about the information provided in a clonoSEQ report, please visit our Reports page.

    ClonoSEQ Ordering ResourceThumbnail ReportsWalkthrough FDA Be8e21ff
    OVERVIEW OF
    CLONOSEQ REPORTS
    Download

    If you have additional questions about a patient report or results, please contact our Clinical Services team by emailing dxsupport@adaptivebiotech.com.

    Submit Your Inquiry

    If you are interested in incorporating the clonoSEQ® Assay into an investigator-sponsored trial (IST), please contact us by filling out the form below.

      Please confirm that you agree you are requesting medical information and certify that you are a physician or healthcare provider, that you are not including any Protected Health Information (PHI), and that the terms of the Adaptive Online Privacy Policy, Terms of Use, HIPAA Notice, and any other Adaptive policies apply.

      Submit Your Inquiry

      If you have a question about a topic not covered elsewhere on this site, please contact us by filling out the form below.

        Please confirm that you agree you are requesting medical information and certify that you are a physician or healthcare provider, that you are not including any Protected Health Information (PHI), and that the terms of the Adaptive Online Privacy Policy, Terms of Use, HIPAA Notice, and any other Adaptive policies apply.

        This page is intended for use by healthcare professionals outside of the United States.

        The clonoSEQ Assay B-cell Reagent Set is an in vitro diagnostic that identifies and quantifies rearranged B-cell receptor gene sequences in DNA extracted from blood and bone marrow.

        It is a manual test that determines measurable/minimal residual disease (MRD) and monitors changes in disease burden during and after treatment in B-cell malignancies. The test is indicated for use by qualified healthcare professionals for clinical decision-making and in conjunction with other clinicopathological features.

        The clonoSEQ Assay is being utilized for a variety of investigator-sponsored clinical trials in B-cell lymphoid cancers. If you are interested in learning more about use of clonoSEQ in your own trials, contact dxsupport@adaptivebiotech.com.